Dosing Commenced in Study of Anti-Tau Agent, FDA Updates Labeling to Glatiramer Acetate Products, Eisai Initiates Rolling Submission for Subcutaneous Lecanemab
Neurology News Network. for the week ending May 18, 2024. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 17, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 17, 2024.
CMSC 2024: What to Expect From This Year's Annual Meeting
The Consortium of Multiple Sclerosis Centers' 38th Annual Meeting will be held Wednesday, May 29, through Saturday, June 1, 2024 at the Music City Center, in Nashville, Tennessee.
Cure SMA Unveils Initiatives to Improve Clinical Trial Accessibility
Cure SMA introduces tools aiding in SMA clinical trial navigation and participation empowerment.
This Week on NeurologyLive® — May 13 2024
Here's some of what is coming soon to NeurologyLive® this week.
PrimeC Performs Well in High-Risk ALS, Patient Death Reported in DAYLIGHT Trial, Donanemab AdComm Hearing Date Announced
Neurology News Network. for the week ending May 11, 2024. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 10, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 10, 2024.
This Week on NeurologyLive® — May 6 2024
ALZ-801 Enters Open-Label Studies, Subcutaneous Ocrelizumab Gets Positive EU Recommendation, FDA Approves Sprinkle Formulation of Valbenazine
Neurology News Network. for the week ending May 4, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — May 3, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 3, 2024.
This Week on NeurologyLive® — April 29, 2024
SAGE-718 Fails Phase 2 Study, Foralumab Dampens Microglial Activation, MDA and FARA Collaborate on Gene Therapy Studies
Neurology News Network. for the week ending April 27, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — April 26, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 26, 2024.
This Week on NeurologyLive® — April 22, 2024
Lecanemab ARIA Rates Unaffected by Centiloid Level, AB-1005 Meets Primary End Point, Fremanezumab Safe in Obese Patients With Migraine
Neurology News Network. for the week ending April 20, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — April 19, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 19, 2024.
This Week on NeurologyLive® — April 15, 2024
Cenobamate Gets New Approved Administration Routes, FDA Agrees to New Trial Design for NurOwn, ENRICH Results Published in NEJM
Neurology News Network. for the week ending April 13, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — April 12, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 12, 2024.
Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease
Sleeping Around the Podcast × NeurologyLive brings you a clinical overview of a newly published study highlighting extracellular vesicle-associated miRNA features that could be diagnostically informative of RBD in patients with Parkinson disease.
This Week on NeurologyLive® — April 8, 2024
Amylyx Pulls ALS Drug AMX0035, Gene Therapy Shows Promise in Giant Axonal Neuropathy, Eisai Submits sBLA for New Lecanemab Dosing
Neurology News Network. for the week ending April 6, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — April 5, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending Aprl 5, 2024.
Sleeping Around the Podcast × NeurologyLive: Parkinson Disease Awareness Month
Sleeping Around the Podcast × NeurologyLive brings you a scientific overview of the crossover between Parkinson disease and sleep disorders.
This Week on NeurologyLive® — April 1, 2024
STK-001 Shows Disease-Modifying Impacts in Dravet, FDA Approves Ravulizumab, Satralizumab Falls Short in Myasthenia Gravis
Neurology News Network. for the week ending March 30, 2024. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — March 29, 2024
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 29, 2024.
TSC Alliance® Highlights Awareness for Purple Day 2024
Purple Day 2024 allows the TSC Alliance to highlight the importance of epilepsy awareness since tuberous sclerosis complex (TSC) is the leading genetic cause of seizures.
This Week on NeurologyLive® — March 25, 2024
SLS-005 Performs Better Without AMX0035, Nerivio Gains Commercial Coverage, UB-312 Reduces α-Synuclein
Neurology News Network for the week ending March 23, 2024. [WATCH TIME: 3 minutes]